<b>Gapping up</b><br/><b>In reaction to strong earnings/guidance:</b> CLF +11.9%, AN +8.5%, LLNW +7.1%, IDTI +6.8%, RTEC +6.8%, ACI +5.8%, HW +5.2%, FN +4.2%, (light volume), SAN +3.3%, AGCO +3.1%, OI +2.8%, SC +2.2%, XL +2.1%, ST +2%, PLAY +1.7%, AGNC +1.6%, (light volume), LYB +1.6%, BP +1.3%, EMR +1.2%, CLR +1.2%, AET +0.7%<br/><br/><b>M&A news</b>: ODP +17.8% (Staples (SPLS) and Office Depot (ODP) are in discussions for possible merger, according to reports), NBG +16.4% (strong in European session), SPEX +16.1% (Board unanimously rejects unsolicited proposal from Marathon Patent Group (MARA)), SPLS +14.1%, CSIQ +5.7% (to acquire Recurrent Energy from Sharp for $265 mln), ADVS +5.5% (SS&C Techs to Acquire Advent Software for $44.25 per share, an enterprise value of approximately $2.7 billion in cash), SSNC +3.1% (SS&C Techs to Acquire Advent Software for $44.25 per share, an enterprise value of approximately $2.7 billion in cash)<br/><b><br/>Select oil/gas related names showing strength:</b> FRO +6.5%, SD +6.4%, BBEP +4%, RIG +3.6%, OAS +3.5%, PBR +2.8%, RDS,A +2.4%, ACMP +1.6%<br/><br/><b>Other news:</b> ESPR +13.9% (announces removal of PPAR Partial Clinical Hold for ETC-1002), LC +9.6% (Lending Club and Alibaba.com (BABA) form strategic alliance), CRNT +8.3% (selected by a large mobile telecommunications service provider for a variety of projects in multiple regions), OCN +7.5% (Kingstown Capital Partners disclosed a 9.5% active stake in 13D filing), EYES +5.3% (announces that InEK1, the German national health insurance system, has renewed Status 1 for the Argus II Retinal Prosthesis System), ANR +4.9% (in sympathy with ACI earnings), EXXI +4.3% (cont pre-mkt vol), FCX +3.2% (underlying commodities trading strong overnight), ARNA +3.2% (announces marketing approval in South Korea of BELVIQ for weight management), BHP +2.9% (underlying commodities trading strong overnight), CTIC +2.7% (announces independent DMC recommendation to continue GOG-0212 Phase 3 study of OPAXIO as maintenance therapy in ovarian cancer), GTE +2.2% (terminates of employment of its CEO; announces 2014 year-end reserves), TEF +2.1% (may use O2 money to fund acquisition of Vivendi's (VIVHY) GVT, according to reports), CRC +1.9% (Soroban Capital Partners disclosed a 9.98% active stake in 13D filing), MNKD +1.9% (Mannkind and Sanofi (SNY) announce Afrezza now available in the US), NOK +1.6% (to repurchase a maximum of 365 mln Nokia shares by using funds in the unrestricted shareholders' equity), CLR +1.2% (announces proved reserves of 1.35 billion barrels of oil equivalent at December 31, 2014)<br/><br/><b>Analyst comments:</b> CRH +3.8% (upgraded to Buy from Hold at Societe Generale), BCS +3.6% (upgraded to Overweight at Morgan Stanley), SSNC +3.1% (upgraded to Overweight from Neutral at JP Morgan), HAWK +2.2% (upgraded to Outperform from Market Perform at BMO Capital), LNKD +2.2% (target raised to $280 from $250 at Goldman; Added to Conviction Buy List), WLL +2.2% (upgraded to Buy from Hold at Stifel), CYT +1.6% (upgraded to Buy from Hold at Jefferies), XEC +1.4% (target raised to $130 from $120 at Stifel), EMC +1.2% (upgraded to Outperform from Neutral at Macquarie)<br/><br/><b>Gapping down</b><br/><b>In reaction to disappointing earnings/guidance:</b> SSYS -27.4%, RCII -14.1%, MNK -3.5%, MTSI -2.5%, (filed for a mixed securities shelf offering for an undisclosed amount; announces proposed public offering of common stock 6.5 mln shares; 4.5 mln by MACOM and 2 mln by John Ocampo), LMNX -2.5%, WEN -1.5%, ADM -1.3%, HIG -1.2%, UPS -1.1%, ARG -1%, IMS -0.7%<br/><br/><b>Other news:</b> RSH -33.4% (co disclosed it received a second notice of default from Salus Capital), ZIOP -8.6% (files mixed securities shelf offering; intends to commence an underwritten public offering of $75,000,000 of shares of its common stock), DDD -7.4% (following SSYS guidance), ONTX -6.6% (announces clinical development plan for Rigosertib in higher risk Myelodysplastic Syndrome (HR-MDS) patients after failure of treatment with hypomethylating agents), XONE -5.9% (following SSYS guidance), PBF -4% (announces an underwritten secondary offering by funds affiliated with The Blackstone Group and First Reserve Management of their remaining 3,804,653 shares of Class A common stock), PRLB -3.8% (following SSYS guidance), BCEI -3.5% (announces the launch of an underwritten public offering of 4 mln shares of its common stock), PEGI -2.1% (announces the commencement of an underwritten public offering of up to $350 mln of shares of its Class A common stock by the Company and the selling shareholder), SABR -2.1% ( announced the public offering of 20 mln shares of common stock by existing stockholders TPG Global and Silver Lake Management Company), BAH -1.6% (announces the sale of an aggregate of 12 mln shares of Class A common stock on an underwritten basis by an affiliate of The Carlyle Group)<br/><br/><b>Analyst comments:</b> PBI -1.1% (lowered to $30 from $33 at Brean Capital), KORS -0.5% (downgraded to Hold from Buy at Canaccord Genuity)<br/> <br/>Allikas: <i>Briefing.com</i>